BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19558693)

  • 21. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective prostaglandin EP4 agonist, APS-999 Na, induces follicular growth and maturation in the rat ovary.
    El-Nefiawy N; Abdel-Hakim K; Kanayama N
    Eur J Endocrinol; 2005 Feb; 152(2):315-23. PubMed ID: 15745941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
    Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
    Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
    Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
    Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.
    Tveteraas IH; Müller KM; Aasrum M; Ødegård J; Dajani O; Guren T; Sandnes D; Christoffersen T
    J Exp Clin Cancer Res; 2012 Sep; 31(1):72. PubMed ID: 22967907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C.
    Fiebich BL; Schleicher S; Spleiss O; Czygan M; Hüll M
    J Neurochem; 2001 Dec; 79(5):950-8. PubMed ID: 11739606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton.
    Martineau LC; McVeigh LI; Jasmin BJ; Kennedy CR
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F693-701. PubMed ID: 14665434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
    Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
    Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
    Li X; Yang B; Han G; Li W
    J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
    Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
    BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
    Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ--prostaglandin E2 dependent proliferation of growth plate chondrocytes.
    Brochhausen C; Neuland P; Kirkpatrick CJ; Nüsing RM; Klaus G
    Arthritis Res Ther; 2006; 8(3):R78. PubMed ID: 16646980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
    Qiu J; Li Q; Bell KA; Yao X; Du Y; Zhang E; Yu JJ; Yu Y; Shi Z; Jiang J
    Br J Pharmacol; 2019 Jun; 176(11):1680-1699. PubMed ID: 30761522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240.
    Hoshikawa H; Goto R; Mori T; Mitani T; Mori N
    Int J Oncol; 2009 Mar; 34(3):847-52. PubMed ID: 19212690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.